Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Alibaba
BABA
|
+$138M |
| 2 |
AbbVie
ABBV
|
+$122M |
| 3 |
Zoom
ZM
|
+$109M |
| 4 |
Amazon
AMZN
|
+$105M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$103M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
Newmont
NEM
|
+$52.9M |
| 4 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 5 |
Yum! Brands
YUM
|
+$34.4M |
Sector Composition
| 1 | Technology | 25.6% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 12.49% |
| 4 | Communication Services | 10.4% |
| 5 | Industrials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PETQ
1851
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.55M | ﹤0.01% |
44,500
+5,900
| +15% | +$206K |
|
|
AIMT
1852
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $1.55M | ﹤0.01% |
92,774
+19,100
| +26% | +$319K |
|
|
HSKA
1853
DELISTED
Heska Corp
HSKA
| $1.55M | ﹤0.01% |
16,600
+2,200
| +15% | +$205K |
|
1854
Vermilion Energy
VET
$1.14B
| $1.54M | ﹤0.01% |
349,067
+47,100
| +16% | +$208K |
|
1855
Clearway Energy Class A
CWEN.A
$3.21B
| $1.54M | ﹤0.01% |
73,450
+6,300
| +9% | +$132K |
|
1856
Acco Brands
ACCO
$361M
| $1.54M | ﹤0.01% |
216,500
+28,000
| +15% | +$199K |
|
1857
OFG Bancorp
OFG
$1.95B
| $1.53M | ﹤0.01% |
114,700
+15,100
| +15% | +$202K |
|
1858
Gossamer Bio
GOSS
$787M
| $1.53M | ﹤0.01% |
117,900
+80,000
| +211% | +$1.04M |
|
1859
AAR Corp
AIR
$2.67B
| $1.53M | ﹤0.01% |
74,100
+9,500
| +15% | +$196K |
|
|
GTHX
1860
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.53M | ﹤0.01% |
63,100
+12,100
| +24% | +$294K |
|
1861
Alaunos Therapeutics
TCRT
$5.1M
| $1.53M | ﹤0.01% |
3,108
+408
| +15% | +$201K |
|
|
SAFE
1862
DELISTED
Safehold Inc.
SAFE
| $1.53M | ﹤0.01% |
26,600
+3,400
| +15% | +$195K |
|
1863
Sapiens International
SPNS
$2.4B
| $1.53M | ﹤0.01% |
57,136
+8,587
| +18% | +$229K |
|
1864
Frontline
FRO
$5.17B
| $1.53M | ﹤0.01% |
221,427
+49,071
| +28% | +$338K |
|
1865
Shutterstock
SSTK
$742M
| $1.53M | ﹤0.01% |
43,600
+5,800
| +15% | +$203K |
|
1866
1st Source
SRCE
$1.55B
| $1.52M | ﹤0.01% |
42,789
+8,200
| +24% | +$292K |
|
1867
Unisys
UIS
$282M
| $1.52M | ﹤0.01% |
139,300
+18,300
| +15% | +$200K |
|
1868
Quince Therapeutics
QNCX
$85.9M
| $1.52M | ﹤0.01% |
+32,800
| New | +$1.52M |
|
1869
Trinseo
TSE
$87.7M
| $1.52M | ﹤0.01% |
68,400
-7,600
| -10% | -$168K |
|
1870
Marcus & Millichap
MMI
$1.26B
| $1.52M | ﹤0.01% |
52,500
+7,000
| +15% | +$202K |
|
1871
RadNet
RDNT
$5.69B
| $1.51M | ﹤0.01% |
95,400
+12,500
| +15% | +$198K |
|
|
VCRA
1872
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $1.51M | ﹤0.01% |
71,200
+10,100
| +17% | +$214K |
|
|
CBB
1873
DELISTED
Cincinnati Bell Inc.
CBB
| $1.51M | ﹤0.01% |
+101,600
| New | +$1.51M |
|
1874
ATN International
ATNI
$238M
| $1.51M | ﹤0.01% |
24,900
+3,200
| +15% | +$194K |
|
1875
ArcBest
ARCB
$1.6B
| $1.5M | ﹤0.01% |
56,700
+7,200
| +15% | +$191K |
|